CH1300646267 - Common Stock

**BG** gets a fundamental rating of **6** out of 10. The analysis compared the fundamentals against 91 industry peers in the **Food Products** industry. **BG** scores excellent on profitability, but there are some minor concerns on its financial health. **BG** has a bad growth rate and is valued cheaply. These ratings could make **BG** a good candidate for value investing.

In the past year **BG** was profitable.

Of the past 5 years **BG** 4 years were profitable.

Measured over the past 3 years, the **Average Return On Invested Capital** for **BG** is above the industry average of **7.75%**.

The 3 year average ROIC (**12.48%**) for **BG** is below the current ROIC(**13.18%**), indicating increased profibility in the last year.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 8.84% | ||

ROE | 18.99% | ||

ROIC | 13.18% |

ROA(3y)7.99%

ROA(5y)4.3%

ROE(3y)21.03%

ROE(5y)11.84%

ROIC(3y)12.48%

ROIC(5y)10.08%

The **Profit Margin** of **BG** (**3.77%**) is comparable to the rest of the industry.

In the last couple of years the **Profit Margin** of **BG** has grown nicely.

In the last couple of years the **Operating Margin** of **BG** has grown nicely.

In the last couple of years the **Gross Margin** of **BG** has grown nicely.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 5.21% | ||

PM (TTM) | 3.77% | ||

GM | 8.09% |

OM growth 3Y15.11%

OM growth 5Y23.32%

PM growth 3Y11.64%

PM growth 5Y49.21%

GM growth 3Y6.55%

GM growth 5Y10.44%

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), **BG** is creating some value.

Compared to 1 year ago, **BG** has more shares outstanding

Compared to 5 years ago, **BG** has more shares outstanding

The debt/assets ratio for **BG** is higher compared to a year ago.

The Debt to FCF ratio of **BG** is **2.23**, which is a good value as it means it would take **BG**, **2.23** years of fcf income to pay off all of its debts.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.41 | ||

Debt/FCF | 2.23 | ||

Altman-Z | N/A |

ROIC/WACC1.73

WACC7.61%

With a decent **Current ratio** value of **2.13**, **BG** is doing good in the industry, outperforming **65.56%** of the companies in the same industry.

A Quick Ratio of **1.20** indicates that **BG** should not have too much problems paying its short term obligations.

With a decent **Quick ratio** value of **1.20**, **BG** is doing good in the industry, outperforming **72.22%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 2.13 | ||

Quick Ratio | 1.2 |

The earnings per share for **BG** have decreased by **-1.80%** in the last year.

Measured over the past years, **BG** shows a very strong growth in **Earnings Per Share**. The EPS has been growing by **55.38%** on average per year.

Looking at the last year, **BG** shows a very negative growth in **Revenue**. The Revenue has decreased by **-11.44%** in the last year.

EPS 1Y (TTM)-1.8%

EPS 3Y25.64%

EPS 5Y55.38%

EPS growth Q2Q14.2%

Revenue 1Y (TTM)-11.44%

Revenue growth 3Y12.87%

Revenue growth 5Y5.41%

Revenue growth Q2Q-10.35%

Based on estimates for the next years, **BG** will show a decrease in **Earnings Per Share**. The EPS will decrease by **-5.43%** on average per year.

The **Revenue** is expected to grow by **0.78%** on average over the next years.

EPS Next Y-13.4%

EPS Next 2Y-5.43%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year-1.34%

Revenue Next 2Y0.78%

Revenue Next 3YN/A

Revenue Next 5YN/A

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

The **Price/Earnings** ratio is **6.81**, which indicates a rather cheap valuation of **BG**.

Based on the **Price/Earnings** ratio, **BG** is valued cheaper than 96.67% of the companies in the same industry.

A **Price/Forward Earnings** ratio of **8.15** indicates a reasonable valuation of **BG**.

Based on the **Price/Forward Earnings** ratio, **BG** is valued cheaply inside the industry as 94.44% of the companies are valued more expensively.

When comparing the **Price/Forward Earnings** ratio of **BG** to the average of the S&P500 Index (**21.38**), we can say **BG** is valued rather cheaply.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 6.81 | ||

Fwd PE | 8.15 |

Based on the **Enterprise Value to EBITDA** ratio, **BG** is valued cheaper than 90.00% of the companies in the same industry.

Based on the **Price/Free Cash Flow** ratio, **BG** is valued cheaper than 91.11% of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 6.19 | ||

EV/EBITDA | 4.17 |

The decent profitability rating of **BG** may justify a higher PE ratio.

PEG (NY)N/A

PEG (5Y)0.12

EPS Next 2Y-5.43%

EPS Next 3YN/A

With a **Yearly Dividend Yield** of **2.92%**, **BG** has a reasonable but not impressive dividend return.

Compared to an average industry **Dividend Yield** of **3.53**, **BG** pays a bit more dividend than its industry peers.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 2.92% |

The dividend of **BG** has a limited annual growth rate of **5.08%**.

Dividend Growth(5Y)5.08%

Div Incr Years3

Div Non Decr Years20

DP17.08%

EPS Next 2Y-5.43%

EPS Next 3YN/A

**BUNGE GLOBAL SA**

NYSE:BG (2/21/2024, 7:04:00 PM)

After market: 93.06 0 (0%)**93.06**

**+1.39 (+1.52%) **

Chartmill FA Rating

GICS SectorConsumer Staples

GICS IndustryGroupFood, Beverage & Tobacco

GICS IndustryFood Products

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap13.52B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 2.92% |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 6.81 | ||

Fwd PE | 8.15 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)0.12

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 8.84% | ||

ROE | 18.99% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 5.21% | ||

PM (TTM) | 3.77% | ||

GM | 8.09% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover2.35

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.41 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 2.13 | ||

Quick Ratio | 1.2 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)-1.8%

EPS 3Y25.64%

EPS 5Y

EPS growth Q2Q

EPS Next Y-13.4%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)-11.44%

Revenue growth 3Y12.87%

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y